HIGHLIGHTS
- who: CAPRIN- et al. from the proved drugs) is currently underway (NCT03872947) in the United States have published the research work: OPEN ACCESS, in the Journal: (JOURNAL) of 20/04/2023
- what: Toxicity Study of TRK-950 in Monkeys Here the authors demonstrate for the first time that CAPRIN-1 is strongly expressed on the cell membrane surface in most solid cancers, but not normal tissues. Because the authors did not find differential splicing for CAPRIN-1, the authors reason that CAPRIN-1 is best classified as a moonlighting protein, which refers to a growing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.